EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Methylprednisolone Modulates the Tfr/Tfh ratio in EAE-Induced Neuroinflammation through the PI3K/AKT/FoxO1 and PI3K/AKT/mTOR Signalling Pathways

Nan Wu, Yun Zhao, Minjun Xiao, Hui Liu, Hongliang Chen, Bin Liu, Xuezhen Wang, Xueli Fan

Inflammation · 2024

DOI: 10.1007/s10753-024-02099-y ↗

Kurz gefasst

Fachartikel in der Zeitschrift Inflammation, 2024. Verfasst von Nan Wu und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurology, Binzhou Medical University Hospital, Binzhou, China. Hauptthemen laut MEDLINE: Encephalomyelitis, Autoimmune, Experimental, Methylprednisolone, T-Lymphocytes, Regulatory, T-Lymphocytes, Helper-Inducer. Die Arbeit wurde bisher 16-mal zitiert (Crossref) und nennt 52 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Methylprednisolone (MP) is a potent glucocorticoid that can effectively inhibit immune system inflammation and brain tissue damage in Multiple sclerosis (MS) patients. T follicular helper (Tfh) cells are a subpopulation of activated CD4 + T cells, while T follicular regulatory (Tfr) cells, a novel subset of Treg cells, possess specialized abilities to suppress the Tfh-GC response and inhibit antibody production. Dysregulation of either Tfh or Tfr cells has been implicated in the pathogenesis of MS. However, the molecular mechanism underlying the anti-inflammatory effects of MP therapy on experimental autoimmune encephalomyelitis (EAE), a representative model for MS, remains unclear. This study aimed to investigate the effects of MP treatment on EAE and elucidate the possible underlying molecular mechanisms involed. We evaluated the effects of MP on disease progression, CNS inflammatory cell infiltration and myelination, microglia and astrocyte activation, as well as Tfr/Tfh ratio and related molecules/inflammatory factors in EAE mice. Additionally, Western blotting was used to assess the expression of proteins associated with the PI3K/AKT pathway. Our findings demonstrated that MP treatment ameliorated clinical symptoms, inflammatory cell infiltration, and myelination. Furthermore, it reduced microglial and astrocytic activation. MP may increase the number of Tfr cells and the levels of cytokine TGF-β1, while reducing the number of Tfh cells and the levels of cytokine IL-21, as well as regulate the imbalanced Tfr/Tfh ratio in EAE mice. The PI3K/AKT/FoxO1 and PI3K/AKT/mTOR pathways were found to be involved in EAE development. However, MP treatment inhibited their activation. MP reduced neuroinflammation in EAE by regulating the balance between Tfr/Tfh cells via inhibition of the PI3K/AKT/FoxO1 and PI3K/AKT/mTOR signalling pathways.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Encephalomyelitis, Autoimmune, ExperimentalMethylprednisoloneT-Lymphocytes, RegulatoryT-Lymphocytes, Helper-InducerNeuroinflammatory DiseasesAnti-Inflammatory AgentsAnimalsTOR Serine-Threonine KinasesMiceProto-Oncogene Proteins c-aktSignal TransductionPhosphatidylinositol 3-KinasesForkhead Box Protein O1FemaleMice, Inbred C57BL

Stichwörter der Autor:innen

PI3K/AKT/FoxO1 signalling pathwayPI3K/AKT/mTOR signalling pathwayT follicular helper (Tfh) cellsT follicular regulatory (Tfr) cellsexperimental autoimmune encephalomyelitis (EAE)multiple sclerosis (MS)

Substanzen

TOR Serine-Threonine KinasesProto-Oncogene Proteins c-aktPhosphatidylinositol 3-KinasesForkhead Box Protein O1MethylprednisolonemTOR protein, mouseFoxo1 protein, mouseAnti-Inflammatory Agents

Autor:innen und Institutionen

  • Department of Neurology, Binzhou Medical University Hospital, Binzhou, China.
  • Institute for Metabolic & Neuropsychiatric Disorders, Binzhou Medical University Hospital, Binzhou, China.
  • Department of Neurology, Binzhou Medical University Hospital, Binzhou, China. xuezhen_wang@126.com.
  • Department of Neurology, Binzhou Medical University Hospital, Binzhou, China. xuelifan@yeah.net.

Förderung

  • National Natural Science Foundation of China

Zitieren

APA

Wu, N., Zhao, Y., Xiao, M., Liu, H., Chen, H., Liu, B., Wang, X., & Fan, X. (2024). Methylprednisolone Modulates the Tfr/Tfh ratio in EAE-Induced Neuroinflammation through the PI3K/AKT/FoxO1 and PI3K/AKT/mTOR Signalling Pathways. Inflammation. https://doi.org/10.1007/s10753-024-02099-y

Vancouver

Wu N, Zhao Y, Xiao M, Liu H, Chen H, Liu B, et al. Methylprednisolone Modulates the Tfr/Tfh ratio in EAE-Induced Neuroinflammation through the PI3K/AKT/FoxO1 and PI3K/AKT/mTOR Signalling Pathways. Inflammation. 2024. doi:10.1007/s10753-024-02099-y

BibTeX
@article{Wu2024,
  author = {Wu, Nan and Zhao, Yun and Xiao, Minjun and Liu, Hui and Chen, Hongliang and Liu, Bin and Wang, Xuezhen and Fan, Xueli},
  title = {Methylprednisolone Modulates the Tfr/Tfh ratio in EAE-Induced Neuroinflammation through the PI3K/AKT/FoxO1 and PI3K/AKT/mTOR Signalling Pathways},
  journal = {Inflammation},
  year = {2024},
  doi = {10.1007/s10753-024-02099-y}
}
Kostenlos starten →